Effect of certain non-steroidal anti-inflammatory drugs on the paraoxonase 2 (PON2) in human monocytic cell line U937

被引:3
作者
Avclkurt, Ayla Solmaz [1 ]
Korkut, Oguzhan [2 ]
机构
[1] Balikesir Univ, Fac Med, Dept Med Biol, Cagis Campus, TR-10145 Balikesir, Turkey
[2] Balikesir Univ, Fac Med, Dept Med Pharmacol, Balikesir, Turkey
关键词
Paraoxonase; paraoxonase; 2; enzyme activity; U937 cell line; HUMAN SERUM; DENSITY-LIPOPROTEIN; OXIDATIVE STRESS; GENE; POLYMORPHISM; LACTONASES; ACTIVATION; DISEASE; LDL;
D O I
10.1080/13813455.2017.1411371
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The paraoxonase gene family in humans consists of three members as PON1, PON2 and PON3. PON2 can be expressed in several tissues; however, it is not released from the cells in those tissues. PON2 is also expressed in macrophages. Firstly, the commonly used NSAIDs diclofenac sodium and tenoxicam were applied on U937 cell line, the in vitro human monocyte cell line. Than PON2 specific Lactonase activity and paraoxonase family specific arylesterase were determined. Use of Diclofenac sodium in 0.845mM dose during 6-12h of incubation and Tenoxicam in 0.74mM dose during 6h of incubation resulted in a significant decline in the lactonase activity. Diclofenac sodium didn't make any change in the arylesterase activity. On the other hand, tenoxicam decreased arylesterase activity during the use of 12h, in 0.74mM and 1.48mM dose.
引用
收藏
页码:378 / 382
页数:5
相关论文
共 32 条
[2]  
Alim Z., 2017, J BIOCHEM MOL TOXIC, V30
[3]   Antidepressant and antipsychotic drugs differentially affect PON1 enzyme activity [J].
Avcikurt, Ayla Solmaz ;
Sinan, Selma ;
Kockar, Feray .
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2015, 30 (02) :245-249
[4]   Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions - A possible peroxidative role for paraoxonase [J].
Aviram, M ;
Rosenblat, M ;
Bisgaier, CL ;
Newton, RS ;
Primo-Parmo, SL ;
La Du, BN .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (08) :1581-1590
[5]   Antiepileptic drugs: Impacts on human serum paraoxonase-1 [J].
Beydemir, Sukru ;
Demir, Yeliz .
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2017, 31 (06)
[6]   An alternative purification method for human serum paraoxonase 1 and its interactions with anabolic compounds [J].
Demir, Dudu ;
Gencer, Nahit ;
Arslan, Oktay .
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2016, 31 (02) :247-252
[7]   Role of PON2 in innate immune response in an acute infection model [J].
Devarajan, Asokan ;
Bourquard, Noam ;
Grijalva, Victor R. ;
Gao, Feng ;
Ganapathy, Ekambaram ;
Verma, Jitendra ;
Reddy, Srinivasa T. .
MOLECULAR GENETICS AND METABOLISM, 2013, 110 (03) :362-370
[8]   In Vitro Inhibition of Three Different Drugs Used in Rheumatoid Arthritis Treatment on Human Serum Paraoxanase 1 Enzyme Activity [J].
Dilek, Esra ;
Polat, Muhammet F. .
PROTEIN AND PEPTIDE LETTERS, 2016, 23 (01) :3-8
[9]   Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities [J].
Draganov, DI ;
Teiber, JF ;
Speelman, A ;
Osawa, Y ;
Sunahara, R ;
La Du, BN .
JOURNAL OF LIPID RESEARCH, 2005, 46 (06) :1239-1247
[10]   Lactonases with oragnophosphatase activity: Structural and evolutionary perspectives [J].
Draganov, Dragomir I. .
CHEMICO-BIOLOGICAL INTERACTIONS, 2010, 187 (1-3) :370-372